Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose domestic vs brand-name esomeprazole dual therapy for Helicobacter pylori eradication
ChiCTR2200056653Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esomeprazole and amoxicillin in Helicobacter pylori infection (3 arms), sponsored by Nanjing First Hospital. Primary endpoint: Helicobacter pylori eradication rate. Started Sep 2021; status: completed.
02
Drugs
esomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200056653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056653.